Breakthrough T1D, Lupus Research Alliance and National MS Society Award Nearly $1M for Autoimmune Research
New York, New York, USA, November 18, 2026 Breakthrough T1D, the Lupus Research Alliance and the National Multiple Sclerosis...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 Clinical Trial Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
New York, New York, USA, November 18, 2026 Breakthrough T1D, the Lupus Research Alliance and the National Multiple Sclerosis...
